NASDAQ:VRNM - Verenium Stock Price, Price Target & More

$3.99 0.00 (0.00 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$3.99
Today's RangeN/A
52-Week Range$2.00 - $4.00
Average Volume240,414 shs
Market Capitalization$51.01 million
P/E RatioN/A
Dividend YieldN/A

About Verenium (NASDAQ:VRNM)

Verenium logoVerenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. As of December 31, 2012, it marketed commercial enzyme products, either independently or in collaboration with its partners. In addition, it has developed a pipeline of enzyme product candidates. Its products are organized into four product lines: animal health and nutrition, grain processing, oilfield services and other industrial processes. As of December 31, 2012, it markets nine commercial enzyme products. In October 2013, BASF SE acquired 71% stake in the Company.

Receive VRNM News and Ratings via Email

Sign-up to receive the latest news and ratings for VRNM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Verenium (NASDAQ:VRNM) Frequently Asked Questions

What is Verenium's stock symbol?

Verenium trades on the NASDAQ under the ticker symbol "VRNM."

Who are some of Verenium's key competitors?

Who are Verenium's key executives?

Verenium's management team includes the folowing people:
  • James H. Cavanaugh Ph.D., Independent Chairman of the Board (Age 77)
  • James E. Levine, President, Chief Executive Officer, Director (Age 43)
  • Jeffrey G. Black, Chief Financial Officer, Senior Vice President (Age 48)
  • Janet S. Roemer, Chief Operating Officer, Executive Vice President - Specialty Enzymes Business Unit (Age 57)
  • Alexander A. Fitzpatrick, Senior Vice President, General Counsel, Secretary (Age 47)
  • John F. Dee, Independent Director (Age 56)
  • Peter R Johnson, Independent Director (Age 61)
  • Fernand J. Kaufmann, Independent Director (Age 70)
  • Holger A. Liepmann, Independent Director (Age 63)
  • Joshua Ruch, Independent Director

Has Verenium been receiving favorable news coverage?

News headlines about VRNM stock have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Verenium earned a media sentiment score of 0.11 on Accern's scale. They also gave media headlines about the biotechnology company an impact score of 44.75 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Verenium?

Shares of VRNM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Verenium's stock price today?

One share of VRNM stock can currently be purchased for approximately $3.99.

How big of a company is Verenium?

Verenium has a market capitalization of $51.01 million.

How can I contact Verenium?

Verenium's mailing address is 3550 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-4318500.

MarketBeat Community Rating for Verenium (VRNM)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Verenium and other stocks. Vote "Outperform" if you believe VRNM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRNM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Verenium (NASDAQ:VRNM) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/21/2016 forward)


Verenium (NASDAQ:VRNM) Earnings History and Estimates Chart

Earnings by Quarter for Verenium (NASDAQ:VRNM)

Verenium (NASDAQ VRNM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2013Q2 2013($0.32)($0.36)$15.70 million$15.39 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.27)($0.47)$13.79 millionViewN/AView Earnings Details
3/27/2013Q4 2012($0.29)($0.28)$14.32 million$13.98 millionViewN/AView Earnings Details
11/8/2012Q312($0.41)$18.42 million$10.26 millionViewN/AView Earnings Details
8/6/2012Q2 2012($0.21)($0.20)ViewN/AView Earnings Details
5/10/2012Q1 2012($0.30)($0.01)ViewN/AView Earnings Details
2/2/2012Q4 2011($0.06)($0.26)ViewN/AView Earnings Details
11/10/2011Q3 2011($0.28)$0.12ViewN/AView Earnings Details
8/9/2011Q2 2011($0.33)($0.16)ViewN/AView Earnings Details
5/12/2011Q1 2011($0.36)($0.23)ViewN/AView Earnings Details
3/1/2011Q4 2010($0.43)($0.36)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.43)($0.54)ViewN/AView Earnings Details
8/9/2010Q2 2010($0.85)($0.30)ViewN/AView Earnings Details
5/10/2010Q1 2010($0.16)($1.05)ViewN/AView Earnings Details
3/11/2010Q4 2009($1.12)($0.30)ViewN/AView Earnings Details
11/9/2009Q3 2009($1.90)($1.16)ViewN/AView Earnings Details
8/10/2009Q2 2009($2.04)($1.66)ViewN/AView Earnings Details
5/11/2009Q1 2009($2.28)($2.32)ViewN/AView Earnings Details
2/23/2009Q4 2008($3.12)($2.24)ViewN/AView Earnings Details
11/10/2008Q3 2008($3.24)($4.93)ViewN/AView Earnings Details
8/7/2008Q2 2008($3.36)($3.17)ViewN/AView Earnings Details
5/19/2008Q1 2008($3.24)($4.56)ViewN/AView Earnings Details
2/25/2008Q4 2007($2.16)($4.26)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Verenium (NASDAQ:VRNM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Verenium (NASDAQ VRNM) Insider Trading and Institutional Ownership History

Insider Trading History for Verenium (NASDAQ:VRNM)

Verenium (NASDAQ VRNM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/18/2013Austin & Greenhouse Da Marxemajor shareholderSell8,100$2.94$23,814.00View SEC Filing  
9/13/2013Austin & Greenhouse Da Marxemajor shareholderSell8,564$2.90$24,835.60View SEC Filing  
9/5/2013Austin W & Greenhouse Da MarxeMajor ShareholderSell10,595$2.74$29,030.30View SEC Filing  
8/7/2013Austin & Greenhouse Da Marxemajor shareholderSell14,200$3.14$44,588.00View SEC Filing  
(Data available from 1/1/2013 forward)


Verenium (NASDAQ VRNM) News Headlines

Calgon Carbon (CCC) vs. Verenium (VRNM) Head-To-Head ComparisonCalgon Carbon (CCC) vs. Verenium (VRNM) Head-To-Head Comparison - March 27 at 8:08 AM
Analyzing Verenium (VRNM) and Calgon Carbon (CCC)Analyzing Verenium (VRNM) and Calgon Carbon (CCC) - March 19 at 11:20 AM
Contrasting Braskem (BAK) and Verenium (VRNM)Contrasting Braskem (BAK) and Verenium (VRNM) - March 5 at 3:08 AM
Financial Comparison: Albemarle (ALB) vs. Verenium (VRNM)Financial Comparison: Albemarle (ALB) vs. Verenium (VRNM) - March 1 at 3:08 PM
Verenium (VRNM) versus Chemours (CC) Financial AnalysisVerenium (VRNM) versus Chemours (CC) Financial Analysis - January 19 at 10:02 AM
Comparing Verenium (VRNM) and Westlake Chemical (WLK)Comparing Verenium (VRNM) and Westlake Chemical (WLK) - January 11 at 1:10 AM
Head to Head Survey: Verenium (VRNM) and Its RivalsHead to Head Survey: Verenium (VRNM) and Its Rivals - December 7 at 9:24 AM
Verenium (VRNM) and The Competition Head to Head ReviewVerenium (VRNM) and The Competition Head to Head Review - December 5 at 5:26 PM
Contrasting Enzymotec (ENZY) and Verenium (VRNM)Contrasting Enzymotec (ENZY) and Verenium (VRNM) - December 2 at 7:18 PM
Comparing CSW Industrials (CSWI) and Verenium (VRNM)Comparing CSW Industrials (CSWI) and Verenium (VRNM) - December 2 at 1:38 PM
Financial Analysis: Verenium (VRNM) and Its CompetitorsFinancial Analysis: Verenium (VRNM) and Its Competitors - November 30 at 1:28 AM
Reviewing Verenium (VRNM) & Its PeersReviewing Verenium (VRNM) & Its Peers - November 26 at 11:20 AM
Head-To-Head Review: Verenium Corp (VRNM) & Its RivalsHead-To-Head Review: Verenium Corp (VRNM) & Its Rivals - November 25 at 3:26 AM
Comparing Verenium Corp (VRNM) & Its PeersComparing Verenium Corp (VRNM) & Its Peers - November 24 at 11:16 PM
Head-To-Head Survey: Verenium Corp (VRNM) and Quaker Chemical Corporation (KWR)Head-To-Head Survey: Verenium Corp (VRNM) and Quaker Chemical Corporation (KWR) - November 19 at 3:28 PM
Contrasting Verenium Corp (VRNM) & Its RivalsContrasting Verenium Corp (VRNM) & Its Rivals - November 18 at 7:24 PM
Contrasting Enzymotec (ENZY) & Verenium Corp (VRNM)Contrasting Enzymotec (ENZY) & Verenium Corp (VRNM) - November 18 at 8:48 AM
Head to Head Review: Verenium Corp (VRNM) & Its RivalsHead to Head Review: Verenium Corp (VRNM) & Its Rivals - November 8 at 2:08 PM

SEC Filings

Verenium (NASDAQ:VRNM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Verenium (NASDAQ:VRNM) Income Statement, Balance Sheet and Cash Flow Statement


Verenium (NASDAQ VRNM) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.